HomeACXP • NASDAQ
add
Acurx Pharmaceuticals Inc
Previous close
$2.02
Day range
$1.98 - $2.08
Year range
$1.17 - $8.82
Market cap
32.62M USD
Avg Volume
100.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
ACN
0.32%
1.32%
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.11M | 56.86% |
Net income | -5.11M | -56.86% |
Net profit margin | — | — |
Earnings per share | -0.38 | -35.71% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.47M | -17.97% |
Total assets | 7.71M | -17.78% |
Total liabilities | 3.04M | 47.57% |
Total equity | 4.67M | — |
Shares outstanding | 15.76M | — |
Price to book | 6.31 | — |
Return on assets | -172.01% | — |
Return on capital | -297.31% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.11M | -56.86% |
Cash from operations | -4.20M | -180.68% |
Cash from investing | — | — |
Cash from financing | 4.62M | 461,963,800.00% |
Net change in cash | 421.86K | 128.21% |
Free cash flow | -2.28M | -735.41% |
About
CEO
Founded
2017
Website
Employees
4